Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator‐activated receptor‐gamma on colorectal cancer in an Indian population
- 12 August 2005
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 96 (8) , 507-512
- https://doi.org/10.1111/j.1349-7006.2005.00072.x
Abstract
The aim of the present study was to investigate associations between Pro12Ala and C161T polymorphisms in the peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) gene and colorectal cancer (CRC) risk. We recruited 301 newly diagnosed CRC patients and 291 healthy control subjects at the Madras Cancer Institute in Chennai, India, from 1999 to 2001. Genotypes of the Pro12Ala and C161T polymorphisms were determined using the PCR‐RFLP method. After adjustment for age, sex, smoking habit, family history and family income, an increased risk of CRC was observed for the C/T + T/T genotype compared to the C/C genotype of the C161T polymorphism (odds ratio = 1.61, 95% confidence interval: 1.10–2.36), whereas no significant association was found for Pro12Ala (odds ratio = 1.06, 95% confidence interval: 0.70–1.61). Analysis with estimated haplotypes showed a significant difference in haplotype frequencies between cases and controls (χ2 = 11.62, P = 0.009, d.f. = 3). The relationship between the two polymorphisms and CRC risk was not significantly modified by dietary intake of fish. Although the biological mechanisms of the observed association remain to be elucidated, our findings suggest that the C161T polymorphism of the PPAR‐γ gene is related to risk of CRC. Further research is needed to investigate functional implications of polymorphisms of the PPAR‐γ gene in CRC development. (Cancer Sci 2005; 96: 507 –512)This publication has 39 references indexed in Scilit:
- No evidence of a role for PPAR?? Pro12Ala polymorphism in endometrial cancer susceptibilityPharmacogenetics, 2004
- The PPAR Pro12Ala polymorphism and risk for incident sporadic colorectal adenomasCarcinogenesis: Integrative Cancer Research, 2004
- Differential effects of the C1431T and Pro12Ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian populationJournal of Lipid Research, 2004
- Dose‐dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligandCancer Science, 2003
- Chemopreventive n-3 fatty acids activate RXR in colonocytesCarcinogenesis: Integrative Cancer Research, 2003
- Fish consumption and colorectal cancer: a case–reference study in JapanEuropean Journal Of Cancer Prevention, 2003
- PPARγ and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's diseaseTrends in Molecular Medicine, 2001
- Accuracy of Haplotype Frequency Estimation for Biallelic Loci, via the Expectation-Maximization Algorithm for Unphased Diploid Genotype DataAmerican Journal of Human Genetics, 2000
- PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoterFEBS Letters, 1998
- Molecular Scanning of the Human Peroxisome Proliferator Activated Receptor γ (hPPARγ) Gene in Diabetic Caucasians: Identification of a Pro12Ala PPARγ2 Missense MutationBiochemical and Biophysical Research Communications, 1997